Benzinga

Benzinga

Benzinga

vendredi, août 28

Cimpress PLC

CMPRNASDAQ
Trade with Public
Trade with Public
$88.50
-0.50-0.56%
Dern. MÀJ: Aug 28, 12:35 PM
AperçuActualitésPrévisions de résultatsÉvénementsObjectifs de coursDonnées financièresSentimentActionnariatComparerOptionsRapport sur les stocks

Cimpress Analyst Price Targets

Wall Street analyst price targets and consensus rating for Cimpress (CMPR).

Price Target Range — 12 Quarters

Analyst Consensus — 2 Analysts

2Buy
Consensus RatingOutperform# Analysts2Avg. Consensus PT$111Upside to Avg. PT+24.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Jul 31, 2026Truist SecuritiesYoussef SqualiPT CutBuy$110→$108
May 6, 2026Barrington ResearchKevin SteinkePT RaiseOutperform$95→$113
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Truist Securities Maintains Buy on Cimpress, Lowers Price Target to $108

Truist Securities analyst Youssef Squali maintains Cimpress (NASDAQ:CMPR) with a Buy and lowers the price target from $110 to $108.
Benzinga Newsdesk

PRO
Barrington Research Maintains Outperform on Cimpress, Raises Price Target to $113

Barrington Research analyst Kevin Steinke maintains Cimpress (NASDAQ:CMPR) with a Outperform and raises the price target from $95 to $113.
Benzinga Newsdesk

PRO
Barrington Research Maintains Outperform on Cimpress, Raises Price Target to $95

Barrington Research analyst Kevin Steinke maintains Cimpress (NASDAQ:CMPR) with a Outperform and raises the price target from $83 to $95.
Benzinga Newsdesk

PRO
Barrington Research Maintains Outperform on Cimpress, Maintains $83 Price Target

Barrington Research analyst Kevin Steinke maintains Cimpress (NASDAQ:CMPR) with a Outperform and maintains $83 price target.
Benzinga Newsdesk

PRO
Barrington Research Maintains Outperform on Cimpress, Raises Price Target to $83

Barrington Research analyst Kevin Steinke maintains Cimpress (NASDAQ:CMPR) with a Outperform and raises the price target from $77 to $83.
Benzinga Newsdesk

Boston Scientific To Rally More Than 35%? Here Are 10 Top Analyst Forecasts For Wednesday

Avi Kapoor

Données et API: API Benzinga · API d'actualités boursières · API de notations d'analystes · API de logo d'entreprise

Données de marché fournies par API Benzinga

Benzinga

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

© 2026 Benzinga | All Rights Reserved